Related Experiment Video
Updated: Jun 23, 2026
Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
P2X7 deficiency attenuates renal injury in experimental glomerulonephritis
Simon R J Taylor1, Clare M Turner, James I Elliott
1MRC Clinical Sciences Centre, Imperial College London, London, United Kingdom.
Abstract:
The P2X7 receptor is a ligand-gated cation channel that is normally expressed by a variety of immune cells, including macrophages and lymphocytes. Because it leads to membrane blebbing, release of IL-1beta, and cell death by apoptosis or necrosis, it is a potential therapeutic target for a variety of inflammatory diseases. Although the P2X7 receptor is usually not detectable in normal renal tissue, we previously reported increased expression of both mRNA and protein in mesangial cells and macrophages infiltrating the glomeruli in animal models of antibody-mediated glomerulonephritis. In this study, we used P2X7-knockout mice in the same experimental model of glomerulonephritis and found that P2X7 deficiency was significantly renoprotective compared with wild-type controls, evidenced by better renal function, a striking reduction in proteinuria, and decreased histologic glomerular injury. In addition, the selective P2X7 antagonist A-438079 prevented the development of antibody-mediated glomerulonephritis in rats. These results support a proinflammatory role for P2X7 in immune-mediated renal injury and suggest that the P2X7 receptor is a potential therapeutic target.
Insights
The P2X7 receptor plays a key role in immune-mediated kidney injury. Blocking this receptor offers significant renoprotection, suggesting it as a therapeutic target for glomerulonephritis.
Area of Science:
- Immunology
- Nephrology
- Pharmacology
Background:
- The P2X7 receptor (P2X7R) is an ion channel on immune cells involved in inflammation.
- P2X7R expression increases in kidney tissue during antibody-mediated glomerulonephritis.
- P2X7R activation can lead to immune cell dysfunction and tissue damage.
Purpose of the Study:
- To investigate the role of P2X7R in antibody-mediated glomerulonephritis.
- To evaluate the therapeutic potential of P2X7R inhibition in renal inflammation.
Main Methods:
- Utilized P2X7R-knockout mice in an experimental glomerulonephritis model.
- Administered a selective P2X7R antagonist (A-438079) to rats with glomerulonephritis.
- Assessed renal function, proteinuria, and kidney histology.
Main Results:
- P2X7R deficiency significantly protected against glomerulonephritis in mice.
- Knockout mice showed improved renal function, reduced proteinuria, and less glomerular injury.
- P2X7R antagonism with A-438079 prevented glomerulonephritis development in rats.
Conclusions:
- P2X7R promotes inflammation and injury in immune-mediated kidney disease.
- Targeting P2X7R represents a promising therapeutic strategy for glomerulonephritis.
